Results 191 to 200 of about 92,291 (256)

An EHA strategic roadmap for improved care in Europe for AYA patients with malignant and chronic non-malignant hematological diseases. [PDF]

open access: yesHemasphere
Castleton A   +11 more
europepmc   +1 more source

A Plug‐and‐Play Platform for Customizing Multivalent Degraders and Degrader‐Drug Conjugates

open access: yesAdvanced Science, EarlyView.
Membrane proteins remain challenging targets for conventional TPD approaches. Here, the authors develop UPTAB, a modular platform leveraging ultrahigh‐affinity orthogonal Im/CL protein pairs for lysosomal degradation of membrane proteins. Mono‐targeted (Type‐I), dual‐targeted (Type‐II), and tri‐targeted (Type‐III) UPTABs enable simultaneous degradation
Mengqing Zhao   +7 more
wiley   +1 more source

The current state of electronic health records across Canada: an environmental scan and interoperability maturity assessment. [PDF]

open access: yesCMAJ
Kannappan S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy